Relevance of the TAS'/PASP Ratio as a Predictor of Outcomes in Patients with Heart Failure with a Reduced Ejection Fraction.
Ilija SrdanovićMaja StefanovićAleksandra MilovančevAleksandra VulinTeodora PantićDragana DabovićSnežana TadićAleksandra IlićAnastazija Stojšić MilosavljevićMarija BjelobrkTatjana MiljkovićLazar VelickiPublished in: Life (Basel, Switzerland) (2024)
This study confirmed previously known independent predictors of adverse outcomes in patients with HfrEF-advanced age, atrial fibrillation, LAVI, and LVEF-but non-invasive parameters of RV-PA coupling TAPSE/PASP and TAS'/PASP improved risk stratification in patients with HFrEF. Variable TAS'/PASP has been shown to be the most powerful, independent predictor of one-year outcome.